FDA Adverse Event Malfunction Summary report: N

ENDOTAK RELIANCE

MDR report key: 2172871 · Received July 22, 2011

Report

Report Number
2124215-2011-10070
Event Type
Malfunction
Date Received
July 22, 2011
Date of Event
June 9, 2011
Report Date
September 20, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
PMA / PMN Number
P910073
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT TO THE POST MARKET QUALITY ASSURANCE LABORATORY, VISUAL INSPECTION REVEALED THREE TERMINAL LEGS WERE RETURNED AND THE LEAD WAS SEVERED. ANALYSIS DETERMINED THE LEAD WAS ELECTRICALLY CONTINUOUS. DUE THE DAMAGED CONDITION OF THE LEAD, NO FURTHER TESTING WAS PERFORMED. ANALYSIS COULD NOT CONFIRM THE REPORTED CLINICAL OBSERVATION.

Additional Manufacturer Narrative · 1

ACCORDING TO AVAILABLE INFORMATION, THIS LEAD AND DEVICE REMAIN IMPLANTED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS EVENT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT POST LEFT VENTRICULAR ASSIST DEVICE PROCEDURE, NO OVERSENSING WAS REVEALED. THE PATIENT WITH THIS DEVICE AND RIGHT VENTRICULAR LEAD HAS AN INTRINSIC ATRIAL ARRHYTHMIA WITH FAST VENTRICULAR CONDUCTION. THE DEVICE HAD BEEN REPROGRAMMED TO AVOID INAPPROPRIATE THERAPY. DURING A FOLLOW UP VISIT, NOISE CAUSING OVERSENSING AND PACING INHIBITION GREATER THAN TWO SECONDS ASYSTOLE WAS NOTED ON THE RIGHT VENTRICULAR ELECTROGRAM. IN ADDITION, NOISE WAS NOTED ON THE SHOCK ELECTROGRAM. THE PATIENT HAD EXPERIENCED AN INAPPROPRIATE SHOCK. THE DEVICE WAS REPROGRAMMED TO MONITOR ONLY. AS THE DEVICE HAS REACHED END OF LIFE AND IS FOR MONITORING PURPOSES ONLY, NO INTERVENTION DECISION HAS BEEN MADE AS OF THIS DATE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0148

Patients

Seq Age Sex Outcome Treatment
1 61 YR Other H199